US Stock MarketDetailed Quotes
XFOR X4 Pharmaceuticals
- 1.150
- +0.070+6.48%
Close May 3 16:00 ET
- 1.140
- -0.010-0.87%
Post 19:30 ET
193.13MMarket Cap-2017P/E (TTM)
1.160High1.080Low2.84MVolume1.110Open1.080Pre Close3.19MTurnover2.18%Turnover RatioLossP/E (Static)167.94MShares2.57552wk High3.78P/B149.73MFloat Cap0.57252wk Low--Dividend TTM130.20MShs Float23.930Historical High--Div YieldTTM7.41%Amplitude0.572Historical Low1.121Avg Price1Lot Size
X4 Pharmaceuticals Stock Forum
Sign in to post a comment
🔔 FDA PDUFA Update…
📣 3 PDUFAs left in April! See summary 👇
🗓️ Last week’s PDUFAs:
$Pfizer(PFE.US$ : Approved 4/26 🎉
⇨ BEQVEZ (fidanacogene elaparvovec-dzkt)
▹ Hemophilia B
▹ BLA
▹ PDUFA date: Q2 2024
$Day One Biopharmaceuticals(DAWN.US$ : Approved 4/23 🎉
⇨ OJEMDA (tovorafenib)
▹ Pediatric low-grade glioma
▹ NDA
▹ PDUFA date: 4/30/24
$ImmunityBio(IBRX.US$ : Approved 4/22 🎉
⇨ Anktiva + BCG
▹ Bladder cancer
▹ resubmitted BLA
▹ PDUFA date: 4/23/24
$Abeona Therapeutics(ABEO.US$ : CRL 4/22 🙁
⚠...
🗓️ Last week’s PDUFAs:
$Pfizer(PFE.US$ : Approved 4/26 🎉
⇨ BEQVEZ (fidanacogene elaparvovec-dzkt)
▹ Hemophilia B
▹ BLA
▹ PDUFA date: Q2 2024
$Day One Biopharmaceuticals(DAWN.US$ : Approved 4/23 🎉
⇨ OJEMDA (tovorafenib)
▹ Pediatric low-grade glioma
▹ NDA
▹ PDUFA date: 4/30/24
$ImmunityBio(IBRX.US$ : Approved 4/22 🎉
⇨ Anktiva + BCG
▹ Bladder cancer
▹ resubmitted BLA
▹ PDUFA date: 4/23/24
$Abeona Therapeutics(ABEO.US$ : CRL 4/22 🙁
⚠...
11
3
A bit more
$X4 Pharmaceuticals(XFOR.US$ FDA Approves X4 Pharmaceuticals' Xolremdi (Mavorixafor) Capsules For Use In Patients 12 Years Of Age And Older With WHIM Syndrome To Increase The Number Of Circulating Mature Neutrophils And Lymphocytes
5
4
News
$X4 Pharmaceuticals(XFOR.US$ X4 Pharmaceuticals Announces FDA Approval of Xolremdi™ (Mavorixafor) Capsules, First Drug Indicated in Patients With Whim Syndrome
2
$X4 Pharmaceuticals(XFOR.US$
NEWS
X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
XOLREMDI™ has been approved by the FDA, marking a significant achievement for X4 Pharmaceuticals. The drug is the first indication for the treatment of WHIM syndrome and has shown positive results in the clinical trial, with improvements in ANC, ALC, and fewer infections. X4 has also received a Rare Pediatric Disease Priority Review...
NEWS
X4 Pharmaceuticals Announces FDA Approval of XOLREMDI™ (mavorixafor) Capsules, First Drug Indicated in Patients with WHIM Syndrome
XOLREMDI™ has been approved by the FDA, marking a significant achievement for X4 Pharmaceuticals. The drug is the first indication for the treatment of WHIM syndrome and has shown positive results in the clinical trial, with improvements in ANC, ALC, and fewer infections. X4 has also received a Rare Pediatric Disease Priority Review...
2
Hmm!
$X4 Pharmaceuticals(XFOR.US$ On FDA PDUFA Calendar for Tuesday 4/30/24! There is still over 100 institutional holders here with a combined total of almost 112 million shares owned! It seems at least some are very confident? Or at least hopeful this gets approval! Hehehe
1
Final Stretch -into 4/26 AH Approval
$Aquestive Therapeutics(AQST.US$
👉🏻Libervant for pediatric - global sales $2-300+ million per year. HUGE 💵 ** Libervant for adults - Globally is at least double that of pediatrics 500 Mil+ 👉🏻 Anaphylm - global sales $1 billion per year if not more FINALLY 👉🏻 AQST 108 (epinephrine cream) for dermatology- Multi hundred millions. ** REACAP Revenue 📈🚀🥇💯 (buyout) hummm 🤔⏰ Small market cap of $328 million is very undervalued. If you added the potential for Libervan...
👉🏻Libervant for pediatric - global sales $2-300+ million per year. HUGE 💵 ** Libervant for adults - Globally is at least double that of pediatrics 500 Mil+ 👉🏻 Anaphylm - global sales $1 billion per year if not more FINALLY 👉🏻 AQST 108 (epinephrine cream) for dermatology- Multi hundred millions. ** REACAP Revenue 📈🚀🥇💯 (buyout) hummm 🤔⏰ Small market cap of $328 million is very undervalued. If you added the potential for Libervan...
2
No comment yet
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
brokeballerrr : .94